Scientists see hope in rare disease drug Wall Street has doubted - STAT

Scientists see hope in rare disease drug Wall Street has doubted - STAT

Scientists see hope in a rare disease drug Wall Street has all but written off

By DAMIAN GARDE

COURTESY AMANDA MOORE

The debate over whether OV101 is a beacon of hope or a scientific nonstarter comes down to the metric Ovid chose to measure its benefits.

READ MORE